Doctor profile · Federal record
Dr. Alan Saven, M.D.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · La Jolla, CA
- NPI 1184680399
- Accepts Medicare
- 44 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
10666 N Torrey Pines RD
La Jolla, CA 920371027
(858) 554-9489
fax (858) 784-5933 - Mailing address
-
10790 Rancho Bernardo RD
San Diego, CA 921275705
Credentials & registration
- NPI registered
- April 2006 — 20 yrs on file
- Profile last updated
- June 1, 2017
- Year of graduation
- 1982 — 44 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- California #A42979
- Medicaid
- CA #00A429790
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1184680399. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
105,389
Distinct HCPCS
10
Medicare allowed
$2,134,385
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9025 |
Injection, azacitidine, 1 mg | 33,525 | 12 | $0 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 27,720 | 14 | $47 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 22,600 | 12 | $3 | |
J0185 |
Injection, aprepitant, 1 mg | 5,590 | 16 | $2 | |
Q5119 |
Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 5,580 | 24 | $28 | |
J1561 |
Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 3,090 | 13 | $47 | |
J1626 |
Injection, granisetron hydrochloride, 100 mcg | 2,180 | 44 | $0 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,236 | 646 | $137 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 794 | 30 | $0 | |
96375 |
Injection of additional new drug or substance into vein | 424 | 62 | $17 |
In context: peer comparison
Among 16 peers in this city , average services per provider: 1,484. This provider delivers 71× the peer median.Open Payments
Industry payments received
All-time total
$17,122
Transactions
43
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| BeiGene USA, Inc. | 7 | $13,423.59 | |
| AstraZeneca Pharmaceuticals LP | 1 | $2,740.00 | |
| Alexion Pharmaceuticals, Inc. | 17 | $543.07 | |
| Gilead Sciences, Inc. | 4 | $107.21 | |
| ABBVIE INC. | 4 | $92.84 | |
| GlaxoSmithKline, LLC. | 4 | $88.74 | |
| SpringWorks Therapeutics, Inc. | 2 | $56.70 | |
| Daiichi Sankyo Inc. | 1 | $20.87 | |
| Sumitomo Pharma America, Inc. | 1 | $18.73 | |
| GENZYME CORPORATION | 1 | $15.73 | |
| Celgene Corporation | 1 | $14.64 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,078
Patients
273
Total drug cost
$6,673,285
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydroxyurea | Generic | 271 | 70 | $13,453 |
| Revlimid (Lenalidomide) | Brand | 123 | 18 | $2,173,697 |
| Acyclovir | Generic | 109 | 30 | $3,061 |
| Imbruvica (Ibrutinib) | Brand | 66 | 0 | $1,247,907 |
| Prochlorperazine Maleate | Generic | 66 | 49 | $1,487 |
| Eliquis (Apixaban) | Brand | 59 | 13 | $57,494 |
| Dexamethasone | Generic | 58 | 28 | $1,297 |
| Lenalidomide | Generic | 56 | 11 | $751,207 |
| Jakafi (Ruxolitinib Phosphate) | Brand | 51 | 0 | $1,022,871 |
| Calquence (Acalabrutinib Maleate) | Brand | 45 | 0 | $652,733 |
Hospital affiliations
Frequently asked questions
What is Dr. Alan Saven's medical specialty?
Dr. Alan Saven practices Hematology & Oncology Physician in La Jolla, CA.
Where does Dr. Alan Saven practice?
Dr. Alan Saven practices at 10666 N Torrey Pines RD, La Jolla, CA 920371027. Office phone: 8585549489.
What is Dr. Alan Saven's NPI?
Dr. Alan Saven's National Provider Identifier (NPI) is 1184680399, issued by NPPES.
Does Dr. Alan Saven accept Medicare assignment?
Yes. Dr. Alan Saven accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Alan Saven commonly perform?
Top Medicare-reported procedures in 2023: Injection, azacitidine, 1 mg (HCPCS J9025); Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS J9144); Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881). Source: CMS Medicare Physician & Other Practitioners file.